PAXMEDICA INC by PaxMedica, Inc. (PXMD) Stock Price, Quote, News & History

Key Statistics

Open

$0.69

Volume / Avg.

0 / 4.63K

Day Range

- - -

52 Wk Range

0.00 - 0.02

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.85

Recent Kuvatris Therapeutics Inc News

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also rose, gaining, 0.80% to 5,164.30.

Avi Kapoor

Nasdaq Down 300 Points; BlackRock Posts Upbeat Earnings

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 500 points on Friday. The Dow traded down 1.37% to 37,934.02 while the NASDAQ fell 1.82% to 16,142.15. The S&P 500 also fell, dropping, 1.61% to 5,115.54.

Avi Kapoor

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Avi Kapoor

Gold Jumps Over 2%; Wells Fargo Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.82% to 38,143.73 while the NASDAQ fell 1.16% to 16,252.28. The S&P 500 also fell, dropping, 0.98% to 5,147.87.

Avi Kapoor

Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies

PaxMedica achieves pivotal milestone with completion of three registration/validation batches for PAX-101, an IV suramin formulation, advancing towards FDA submission in Q4 2024. Potential breakthrough treatment for Stage 1 HAT, a fatal tropical disease.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.62M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

6.91M

Free Cash Flow (TTM)

-7.62M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-708.11K

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$381.72K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

488000.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.02

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$444.86K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

$316.92K

Key Statistics

Open

$0.69

Volume / Avg.

0 / 4.63K

Day Range

- - -

52 Wk Range

0.00 - 0.02

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.85

About

Sector

Health Care

Industry

Pharmaceuticals

PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

PXMD

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

PXMD

FAQ

How do I buy PAXMEDICA INC by PaxMedica, Inc. (PXMD) stock?

You can purchase shares of PAXMEDICA INC by PaxMedica, Inc. (OTCEM:PXMD) through any online brokerage.

View our list of the best stock brokerages

Who are PAXMEDICA INC by PaxMedica, Inc. (PXMD) competitors?

There are no as such competitors for PAXMEDICA INC by PaxMedica, Inc..

What is the forecast, or price target, for PAXMEDICA INC by PaxMedica, Inc. (PXMD) stock?

PAXMEDICA INC by PaxMedica, Inc. has a consensus price target of $3.00.

What is the current price for PAXMEDICA INC by PaxMedica, Inc. (PXMD)?

The stock price for PAXMEDICA INC by PaxMedica, Inc. (OTCEM: PXMD) is $0.0005 last updated August 10, 2026 at 9:30 AM EDT.

Does PAXMEDICA INC by PaxMedica, Inc. (PXMD) pay a dividend?

There are no upcoming dividends for PAXMEDICA INC by PaxMedica, Inc..

When is PAXMEDICA INC by PaxMedica, Inc. (OTCEM:PXMD) reporting earnings?

PAXMEDICA INC by PaxMedica, Inc. does not have any upcoming earnings scheduled.

Is PAXMEDICA INC by PaxMedica, Inc. (PXMD) going to split?

There is no upcoming split for PAXMEDICA INC by PaxMedica, Inc..

What sector and industry does PAXMEDICA INC by PaxMedica, Inc. (PXMD) operate in?

PAXMEDICA INC by PaxMedica, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.